BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20101205)

  • 1. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.
    Soto-Reyes E; Recillas-Targa F
    Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulation of tumor suppressor genes by the nuclear factor CTCF.
    Recillas-Targa F; de la Rosa-Velázquez IA; Soto-Reyes E
    Biochem Cell Biol; 2011 Oct; 89(5):479-88. PubMed ID: 21846316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor.
    Lutz M; Baniahmad A; Renkawitz R
    Biochem Soc Trans; 2000; 28(4):386-9. PubMed ID: 10961925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
    Bocchetta M; Eliasz S; De Marco MA; Rudzinski J; Zhang L; Carbone M
    Cancer Res; 2008 Feb; 68(4):1022-9. PubMed ID: 18281476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and epigenetics of the multifunctional protein CTCF.
    Filippova GN
    Curr Top Dev Biol; 2008; 80():337-60. PubMed ID: 17950379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
    Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
    Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTCF binds the proximal exonic region of hTERT and inhibits its transcription.
    Renaud S; Loukinov D; Bosman FT; Lobanenkov V; Benhattar J
    Nucleic Acids Res; 2005; 33(21):6850-60. PubMed ID: 16326864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
    Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
    Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus.
    Rodriguez C; Borgel J; Court F; Cathala G; Forné T; Piette J
    Biochem Biophys Res Commun; 2010 Feb; 392(2):129-34. PubMed ID: 20051228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus.
    Splinter E; Heath H; Kooren J; Palstra RJ; Klous P; Grosveld F; Galjart N; de Laat W
    Genes Dev; 2006 Sep; 20(17):2349-54. PubMed ID: 16951251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.